Cargando…
Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis
Cystic fibrosis (CF) is a rare genetic disease that affects the respiratory and digestive systems. Lung disease is variable among CF patients and associated with the development of comorbidities and chronic infections. The rate of lung function deterioration depends not only on the type of mutations...
Autores principales: | Pineau, Fanny, Caimmi, Davide, Magalhães, Milena, Fremy, Enora, Mohamed, Abdillah, Mely, Laurent, Leroy, Sylvie, Murris, Marlène, Claustres, Mireille, Chiron, Raphael, De Sario, Albertina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164665/ https://www.ncbi.nlm.nih.gov/pubmed/32302349 http://dx.doi.org/10.1371/journal.pone.0231285 |
Ejemplares similares
-
DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis
por: Magalhães, Milena, et al.
Publicado: (2017) -
DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study
por: Pineau, Fanny, et al.
Publicado: (2021) -
Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics
por: Caimmi, Silvia, et al.
Publicado: (2012) -
Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
por: Caimmi, Davide, et al.
Publicado: (2018) -
Rhinovirus‐associated pulmonary exacerbations show a lack of FEV
(1) improvement in children with cystic fibrosis
por: Cousin, Mathias, et al.
Publicado: (2016)